|Bid||108.29 x 300|
|Ask||108.30 x 200|
|Day's Range||107.00 - 108.63|
|52 Week Range||88.90 - 123.55|
|PE Ratio (TTM)||23.97|
|Forward Dividend & Yield||4.28 (4.04%)|
|1y Target Est||N/A|
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Philip Morris International, Inc. a score of 59. Our analysis is based on comparing Philip Morris International, Inc. with the following peers – Altria Group, Inc., British American Tobacco PLC Sponsored ADR, Imperial Brands PLC Sponsored ADR, Vector Group Ltd. and 22nd Century Group, Inc. (MO-US, BTI-US, ... Read more (Read more...)
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Philip Morris International, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)
Of the 15 analysts that follow Altria Group, 53.3% recommend a “buy,” and 46.7% recommend a “hold.” None of the analysts recommend a “sell” option.
For the next four quarters, analysts expect Philip Morris and Altria Group to post EPS growth of 16.5% and 11.1%, respectively.
For the next four quarters, analysts expect Altria to post gross margin, EBITDA margin, and net margin readings of 62.1%, 52.2%, and 33.6%, respectively.
For the next four quarters, analysts expect Philip Morris International (PM) to post revenues of ~$31.3 billion.
In 3Q17, Philip Morris International (PM) posted net revenues of ~$7.5 billion, which was 3.2% lower than the analyst estimate of ~$7.7 billion.
In 3Q17, Philip Morris posted adjusted earnings per share of $1.27 on revenues of ~$7.5 billion. Altria Group posted adjusted earnings per share of $0.90 on revenues of $5.1 billion.
Let’s talk about the popular Philip Morris International Inc (NYSE:PM). The company’s shares saw significant share price volatility over the past couple of months on the NYSE, rising to theRead More...
The U.S. Food and Drug Administration said on Wednesday it is considering measures to speed development of products that help people quit smoking, including easing requirements for approval of over-the-counter nicotine replacement therapies. The agency said it is "re-evaluating and modernizing" its approach to regulating nicotine replacement therapies (NRT), which are typically sold as gums, patches and lozenges. Because their effectiveness is limited, the FDA wants to give consumers a wider range of options.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Philip Morris International, Inc. Here are 5 ETFs with the largest exposure to PM-US. Comparing the performance and risk of Philip Morris International, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
One of the best paying dividend stock on our list is Philip Morris International. Dividend stocks are a great way to hedge your portfolio as they provide both steady incomeRead More...
Nov.29 -- Andre Calantzopoulos, Philip Morris International chief executive officer, discusses the company's bet on smoke-free products with Bloomberg's Kevin Cirilli on "Bloomberg Markets: Balance of Power."